[1]
Al-Hasso, I.K.Q. 2024. Evaluation of Interleukin-22 and Toll-like receptor-2 as an Immunological Biomarkers in Breast Cancer Patients. AL-Kindy College Medical Journal. 20, 2 (Aug. 2024), 97–100. DOI:https://doi.org/10.47723/3sfb2q82.